Skip to content

News

California Biomedical Leaders Weigh in on Future of Biomed Innovation

11.07.2011 — CHI-California Healthcare Institute, a non-profit public policy research organization, today released a series of videos featuring top California biomedical leaders with their perspectives on the future of the biomedical industry. Business and academic leaders discuss the environment for biomedical innovation, including research initiatives, investment opportunities, and U.S. regulatory policies. Industry executives, analysts and a patient advocate discuss their own views on the subject of FDA regulation and access to innovative therapies. Read More

Sacramento at a Glance

Get your weekly report about what's going on in Sacramento

Latest Issue:
Sacramento at a Glance — For the Week of Jan. 23, 2012

Washington Report

Stay up to date on federal issues with the Washington Report

Latest Issue:
Washington Report – Dec. 6, 2011, Vol. 7 No. 18

CHI Bulletin

Get the latest CHI news and view past Bulletins

Latest Issue:
CHI Bulletin – Jan. 20, 2012, Vol. 18, No. 1

CHI - PAC Logo

Bookmark and Share

2012

February

02.03.2012
CHI Blog Explores Higher Education with UC Davis Biotech Director

02.03.2012
CHI Board Member Topol Pens New Digital Health Book

02.03.2012
Scripps Research Demonstrates New Blood Test Potential for Cancer Detection

02.02.2012
Roche Issues Positive Outlook

02.01.2012
CHI CEO Provides Testimony Before Congress on User Fees

January

01.31.2012
UC Davis Researchers Tackle Huntington’s Disease

01.30.2012
CHI Members, Governments Unite to Combat Neglected Tropical Diseases

01.30.2012
Skin Cancer Drug Earns FDA Approval

01.27.2012
FDA Gives Bydureon the Green Light

01.27.2012
FDA Deadline Nears for Amylin Diabetes Drug

2011

December

12.22.2011
CHI Offices Closed for the Holidays

12.21.2011
Pfizer Submits FDA Application for Arthritis Drug

12.21.2011
Takeda Inks $310 Million Deal for Intellikine

12.20.2011
Amgen, Watson to Develop Cancer Biosimilars in $400 Million Deal

12.19.2011
Burrill Raises $313 Million Toward Life Sciences Investment Fund

View Archives